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Xanthoma disseminatum (XD) is a rare subtype of
non-Langerhan’s cell histiocytosis (non-LCH). To
date, just greater than 100 cases of XD have been
reported; however, association with hyperlipidemia
is extremely rare. We present a unique case of XD
associated with familial hypertriglyceridemia
(FHTG). Additionally, the patient had an extensive
K€oebner response.CASE REPORT
A 37-year-old man, farmer by occupation, pre-
sented with numerous asymptomatic raised skin
lesions of 2 months’ duration and hoarseness of
voice for the past 2 weeks. He was otherwise
healthy, and none of his family members had similar
skin lesions. Physical examination found multiple
discrete skin-colored and yellow dome-shaped firm
papulonodules distributed symmetrically over the
face, trunk, and extremities (Fig 1, A). An extensive
K€oebner response was seen over the chest and
shoulder (Fig 1, A) at sites of contact with the
shoulder straps of an insecticide sprayer tank
fastened to his back. Skin lesions had a predilection
for flexural and intertriginous areas (Fig 1, B). An
indirect laryngoscopy found numerous yellow pap-
ulonodules in the larynx. Dermoscopy of skin
lesions on chest is shown in Fig 2, C. Systemic
examination was normal. Results of routine labora-
tory investigations, including a complete blood
count, erythrocyte sedimentation rate, fasting blood
sugar, blood urea and serum creatinine, and liver andthe Department of Dermatology, Venereology, and Leprosy,
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hoo.com.thyroid function tests were normal. His total choles-
terol was 138 mg/dL (normal \200); triglycerides,
205 mg/dL (normal \150); very low-density lipo-
protein (VLDL), 41 mg/dL (normal\30); low-density
lipoprotein (LDL) cholesterol, 80 mg/dL (normal
\100); and high-density lipoprotein (HDL) choles-
terol, 17 mg/dL (normal[40). His serum osmolarity
and electrolytes were also normal, and magnetic
resonance imaging of the brain did not find any
abnormality. Serum protein electrophoresis did not
show any M band. Urine examination was negative
for Bence Jones proteins. Skeletal survey was also
normal. Fasting lipid profile of his father found
elevated triglycerides (348 mg/dL), high VLDL
(69 mg/dL), low HDL (32 mg/dL), and normal levels
of total cholesterol and LDL.
Histopathologic examination of a punch biopsy
specimen obtained from a nodule on the
back was consistent with xanthoma (Fig 2, A).
Immunohistochemistry was positive for CD68 (Fig
2, B) but negative for S100 and CD1a. Based on his
clinical, histologic and immunohistochemical fea-
tures and lipid derangements in our patient and his
father, a final diagnosis of xanthoma disseminatumJAAD Case Reports 2016;2:253-6.
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Fig 1. A, Xanthoma disseminatum shows numerous
lesions on the chest and shoulder. Koebnerization is
seen on sides of the chest and shoulder. B, Yellowish
nodules grouped together in the left groin fold.
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admitted in the dermatologyward and started on oral
thalidomide, 100 mg, to be taken every night. On the
fourth day of admission, he complained of breath-
lessness that was relieved after the addition of a short
course of oral prednisolone. Shortly thereafter, he
had giddiness that warranted the discontinuation
of thalidomide. We then started oral simvastatin,
10 mg/d, and fenofibrate, 200 mg/d, with the twin
aim of correcting lipid abnormalities and improving
mucocutaneous lesions. After 6 months of treatment
on this combined regime, triglycerides and HDL
levels showed significant improvement, progression
of mucocutaneous lesions was arrested, and skin
lesions began to flatten, soften, and turn brown in
color.
DISCUSSION
XD is clinically characterized by multiple yellow-
brownish papulonodules over the body with a
predilection for the flexural and intertriginous areas
and mucous membranes. Historically, XD was
described to follow 1 of 3 clinical patterns: a
common persistent form, a progressive form, and a
rare spontaneously regressing form.1 Although
cutaneous lesions are bothersome, involvement of
mucosae and internal organs can result in
significant morbidity and mortality. Systemic associ-
ations include central diabetes insipidus owing to
involvement of pituitary stalk and paraproteinemias,such as multiple myeloma. Histopathologic
examination of early lesions of XD shows a
predominance of scalloped histiocytes, whereas
more established lesions consist mainly of foamy
histiocytes with few scalloped cells. In the most
established or mature lesions, a mixture of scalloped
cells, foam cells, lymphocytes, and Touton giant cells
are seen.
The main differential diagnosis in our patient
included eruptive xanthomas and other non-LCH
disorders. Eruptive xanthomas are small yellowish
papules with an erythematous halo distributed
over the buttocks, shoulder, and extensor aspect
of limbs; they commonly appear in crops and
resolve spontaneously within few weeks, although
lesions may wax and wane with plasma triglycer-
ide levels. In eruptive xanthomas, triglyceride
levels are usually greater than 1000 mg/dL, and
mucosae are uninvolved. Tuberous and tendon
xanthomas are associated with raised total
cholesterol and LDL levels. Other non-LCH
disorders, such as generalized eruptive histiocyto-
sis, progressive nodular histiocytosis, multicentric
reticulohistiocytosis, and Erdheim-Chester disease
can be differentiated from XD mainly based on the
distribution of lesions; mucosal involvement and a
predilection for the flexural and intertriginous
areas would favor a diagnosis of XD. Erdheim-
Chester disease is a multisystemic non-LCH
characterized by involvement of bones, visceral
organs, central nervous system, and skin xantho-
mas.2 In Erdheim-Chester disease, skeletal
radiographs would show the characteristic features
of symmetric sclerosis involving the distal portions
of long bones.2 Recently, molecular genetic clonal
markers have been identified in histiocytic disor-
ders, such as generalized eruptive histiocytosis and
Erdheim-Chester disease. Such markers would
make the distinction among histiocytic disorders
more accurate because the phenotypic markers
(F131/fascin/S100-) are less so. Our patient also
presented with an extensive K€oebner phenome-
non. Earlier, Ghorpade3 described a patient with
XD who had a K€oebner response consisting of a
few linear papules on the shaft of penis.
The association of lipid abnormalities with XD is
exceedingly uncommon. FHTG is an autosomal
dominant disorder of lipid metabolism that
results from an overproduction of VLDL by the
liver and impaired catabolism of triglyceride-rich
lipoproteins. There are only 2 previous reports of
hypertriglyceridemia in association with XD.4,5
However, in these reports, lipid profiles of family
members were unavailable.4,5 Because the major
class of lipoprotein elevated is VLDL, FHTG is also
Fig 2. A, Histopathology found diffuse dermal infiltrate composed of foamy histiocytes along
with occasional scalloped histiocytes, lymphocytes, and Touton giant cells. B, Immunohisto-
chemistry shows CD681 cells in the dermis. C, Dermoscopy shows yellowish globules. (A,
Hematoxylin-eosin stain; original magnifications: A and B, 320.)
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Diagnosis of FHTG is usually suspected by the
triad of elevated plasma triglycerides, normal or
mildly raised total cholesterol, and reduced plasma
HDL cholesterol levels. Identification of a similar
lipid abnormality in a first-degree relative confirms
the diagnosis of FHTG.7
The exact molecular mechanisms underlying the
plasma lipid abnormalities in XD are unknown.
Interestingly in hemophagocytic lymphohistiocyto-
sis, a histiocytic disorder resulting from overpro-
duction and activation of histiocytes and T cells,
plasma triglyceride levels are often elevated.8
Studies have found that tumor necrosis factor
alpha inhibits the lipoprotein lipaseesecreting
activity of macrophages leading to hypertriglycer-
idemia.9 However, we were unable to concur
whether such a mechanism was responsible for
hypertriglyceridemia because our patient had
FHTG.
Treatment of XD is challenging. Several medica-
tions including statins, fibrates, glitazones, azath-
ioprine, cyclophosphamide, prednisolone, and
thalidomide have been tried with variable results,
but most success seems to be noted with 2-
chlorodeoxyadenosine.4 The anti-inflammatory and
lipid-lowering effects of statins and fibrates wereused for the treatment of XD and familial hyper-
triglyceridemia in our patient.
CONCLUSIONS
Plasma lipid levels should be evaluated in all
patients with xanthoma disseminatum, including
their family members. We also suggest for the inclu-
sion of xanthoma disseminatum in the differential
diagnosis of dermatoses exhibiting the K€oebner
phenomenon.
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